Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

A Novel Oxidative Stress-Responsive Apoptosis Inducing Protein (ORAIP) may have Possible Effects on Immune Disorders

Yoshinori Seko

We previously identified a novel apoptosis inducing humoral factor in the conditioned medium of hypoxic/ reoxygenated cardiac myocytes. Myocardial ischemia/reperfusion markedly increased plasma ORAIP levels and myocardial ischemia/reperfusion injury was clearly suppressed by neutralizing anti-ORAIP antibodies in vivo. We named this novel post-translationally modified secreted-form of eukaryotic translation initiation factor 5A, as Oxidative Stress-Responsive Apoptosis Inducing Protein (ORAIP). Evidence has accumulated that ORAIP may be a common and the dominant apoptosis-inducer among various cell types in response to various types of oxidative stress involved in a wide spectrum of acute and chronic disorders. We found infiltrating immune cells strongly expressed ORAIP in the tissues with myocarditis, aortitis, and atherosclerosis, suggesting that ORAIP-mediated apoptotic signalling may play a role in the pathogenesis involved. Further investigation is needed to confirm whether ORAIP can be a sensitive biomarker and a therapeutic target for the cell injury involved in immune disorders.